Is Probiotic Digestive Health Randomized Trial safe?

The current Migaku evidence database contains 2 reusable source documents for Probiotic Digestive Health Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Probiotic blend effectively alleviated symptoms of FC and improved physical well-being. [Park HG (2026); evidence level 2] - We aimed to evaluate the efficacy and safety of a spore-forming probiotic blend containing Clostridium butyricum IDCC 1301, Weizmannia coagulans IDCC 1201, and Bacillus subtilis IDCC 1101 for improving bowel function and well-being in adults with functional constipation (FC). [Park HG (2026); evidence level 2] - In a randomized, double-blind, placebo-controlled trial, 78 adults with FC (Rome IV criteria) received either probiotic blend (n = 40) or placebo (n = 38) daily for 4 weeks. [Park HG (2026); evidence level 2] - Background Emerging evidence suggests gut microbiota modulation may influence neurocognitive function through the gut-brain axis. [Huang J (2025); evidence level 2] - The findings may inform the development of strategies to delay cognitive decline by modulating the gut-brain axis in this high-risk population. [Huang J (2025); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.